Development and validation of a “capture‐fusion” model to study drug sensitivity of patient‐derived hepatitis C

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|4|1192-1204

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.4, 2015-04, pp. : 1192-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A monocytic detour to replicate patient‐derived hepatitis C virus in hepatoma cells and its use for phenotypic analyses

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1112-1114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 8, 2015-04 ,pp. : 1967-1975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiation sensitivity assay with a panel of patient‐derived spheroids of small cell carcinoma of the cervix

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2949-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of pediatric liver cancer patient–derived xenograft platforms for pediatric liver cancer: A critical stage in the development of anticancer treatments

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1017-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?

By Jin Ketao   He Kuifeng   Li Guangliang   Teng Lisong  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 597-606

Future Medicine

Access to resources Recommend Favorite